RAVERA, Mauro
 Distribuzione geografica
Continente #
EU - Europa 6.463
NA - Nord America 6.278
AS - Asia 3.864
SA - Sud America 688
AF - Africa 133
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 17.443
Nazione #
US - Stati Uniti d'America 6.100
RU - Federazione Russa 1.694
IE - Irlanda 1.387
SG - Singapore 1.163
CN - Cina 1.012
DE - Germania 841
SE - Svezia 692
HK - Hong Kong 597
UA - Ucraina 547
VN - Vietnam 535
BR - Brasile 528
IT - Italia 402
FI - Finlandia 352
FR - Francia 246
IN - India 162
GB - Regno Unito 123
CA - Canada 111
BD - Bangladesh 76
AR - Argentina 63
KR - Corea 59
MX - Messico 46
ID - Indonesia 41
BJ - Benin 40
ZA - Sudafrica 39
IR - Iran 37
PL - Polonia 37
EC - Ecuador 32
TR - Turchia 32
ES - Italia 26
JP - Giappone 26
BE - Belgio 23
IQ - Iraq 19
AT - Austria 18
PK - Pakistan 18
CO - Colombia 17
NL - Olanda 17
CL - Cile 16
LT - Lituania 15
UZ - Uzbekistan 15
EG - Egitto 14
VE - Venezuela 13
MA - Marocco 11
RO - Romania 11
EU - Europa 10
SA - Arabia Saudita 10
PY - Paraguay 9
JO - Giordania 8
TN - Tunisia 7
AL - Albania 6
AU - Australia 6
NP - Nepal 6
PH - Filippine 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
HR - Croazia 5
IL - Israele 5
UY - Uruguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
HN - Honduras 4
KE - Kenya 4
PA - Panama 4
CI - Costa d'Avorio 3
ET - Etiopia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
Totale 17.433
Città #
Dublin 1.379
Jacksonville 991
Hong Kong 594
San Jose 578
Dearborn 542
Singapore 467
Ashburn 378
Beijing 307
New York 257
Chandler 253
Wilmington 237
Moscow 218
Los Angeles 177
Lauterbourg 176
Ho Chi Minh City 173
Lawrence 173
Princeton 173
Ann Arbor 160
San Mateo 128
Council Bluffs 122
Hanoi 114
Andover 108
Piemonte 104
Buffalo 93
Munich 80
São Paulo 61
Toronto 61
Seoul 54
Santa Clara 52
Orem 51
Dallas 49
Grafing 48
Bremen 43
Novara 41
Cotonou 40
Frankfurt am Main 37
Redondo Beach 37
Helsinki 33
Hefei 32
Denver 31
Nanjing 30
Houston 29
Montreal 28
Warsaw 27
Chennai 26
Atlanta 25
Da Nang 25
Woodbridge 25
Guangzhou 24
Chicago 23
Kunming 23
Tokyo 23
Brooklyn 22
Haiphong 22
Mexico City 22
Monmouth Junction 22
Stockholm 22
Boardman 21
Norwalk 21
Brussels 20
Leawood 20
Cave Creek 19
Hangzhou 19
Johannesburg 19
London 19
Rio de Janeiro 18
Milan 17
Biên Hòa 16
Mumbai 16
Nuremberg 16
Zanjan 16
Manchester 15
Tashkent 15
Tianjin 15
Turin 15
Columbus 14
Poplar 14
Fairfield 13
Ardabil 12
Augusta 12
Belo Horizonte 12
Hải Dương 12
Ankara 11
Brasília 11
Jinan 11
Kocaeli 11
Quito 11
Seattle 11
Shanghai 11
Turku 11
Amsterdam 10
Boston 10
Guayaquil 10
Hebei 10
Jakarta 10
Ninh Bình 10
Phoenix 10
Rome 10
San Francisco 10
Wuhan 10
Totale 9.664
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 165
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 157
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 152
A view on multi-action Pt(IV) antitumor prodrugs 148
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 147
Transition metal carbonyl clusters in biology: A futile or niche research area? 143
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 142
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 139
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 138
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 138
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 136
A different way for the oxidation of the Pt(II) complexes 135
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 135
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 135
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 134
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 134
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 131
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 131
Different strategies to exploit Pt(IV) complexes as pro-drugs 130
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 130
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 130
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 130
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 129
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 128
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 127
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 126
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 125
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 125
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 124
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 124
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 123
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 122
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 121
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 120
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 114
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 114
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 112
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 112
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 111
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 111
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 111
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 110
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 110
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 109
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 108
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 108
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 106
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 106
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 105
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 104
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 103
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 101
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 101
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 101
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 100
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 100
Pt(IV) complexes as anticancer prodrugs 100
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 100
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 99
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 98
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 98
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 97
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 96
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 95
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 95
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 95
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 94
Inhibition of telomerase activity by platinum derivatives 92
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 92
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 92
New strategies to overcome therapeutic resistance in glioblastoma 92
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 91
Characterization of 37 enological tannins using a multiple technique approach: Linear sweep voltammetry as a rapid method both for classification and determination of antioxidant properties 90
Electron Interactions in Cluster Dimers. An Electrochemical Approach 90
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 90
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 89
Synthesis and in-vitro cytotoxicity of cis,cis,trans-diammine dichlorido disuccinatoplatinum(IV)-peptide bioconjugates 88
Electrochemical, Theoretical and Structural Investigations on the "Butterfly" Co4(CO)8L2(RC2R) (L=CO, PPh3, R=H, Et, Ph) Cluster 87
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 87
A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line 86
The Stepwise Reduction of Dinitrogen Occurring on a Divanadium Model Compound: A Synthetic, Structural, Magnetic, Electrochemical and Theoretical Investigation on the [V=N=N=V]n+ [n = 4, 5, 6] Based Complexes 86
Over 100 Years of Research on Cyclopentadienylironcarbonyl Chemistry: Microscale-Integrated Organometallic Experiments 85
Electron Interactions in Cluster Diynes. An Electrochemical Approach 85
Experimental determination and modeling of the lipophilicity in platinum complexes 85
Targeting and delivery of Pt(II) antiproliferative drugs 85
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 85
Stabilization of carbenium ions derived from ethynylestradiol by different adjacent organometallic moieties. Implication in the inactivation of the estrogen receptor 85
The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor 83
The interaction between platinum(II) antiproliferative drugs and DNA evaluated by means of an electrochemical biosensor 83
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 82
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 82
Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent 81
Totale 11.065
Categoria #
all - tutte 89.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/20221.220 69 20 171 141 57 0 161 28 80 22 214 257
2022/20232.614 186 93 170 65 147 244 55 134 1.377 34 77 32
2023/2024763 54 62 76 14 138 0 136 11 9 4 132 127
2024/20251.763 17 53 99 42 74 188 197 98 389 210 83 313
2025/20267.207 372 318 589 1.103 594 485 1.021 1.215 505 484 357 164
Totale 17.658